{
    "medicine_id": "81d695646cc9bded47a637637d1e1436396d2f63",
    "platform_id": "DB05829",
    "metadata": {
        "name": "Natpar 100 MCG Injection powder for solution",
        "composition": "100 MCG Parathyroid hormone",
        "clinical_particulars": {
            "therapeutic_indications": "For use treatment in osteoporosis",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Parathyroid hormone is responsible for the fine regulation of serum calcium concentration on a minute to minute basis This is achieved by the acute effects of the hormone on calcium resorption in bone and calcium reabsorption in the kidney The phosphate mobilized from bone is excreted into the urine by means of the hormone s influence on renal phosphate handling Parathyroid hormone also stimulates calcium absorption in the intestine this being mediated indirectly by 1 25 dihydroxyvitamin D Thus a hypocalcemic stimulus of parathyroid hormone secretion results in an increased influx of calcium from three sources bone kidney and intestine resulting in a normalization of the serum calcium concentration without change in the serum phosphate concentration",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00390",
                        "description": "The risk or severity of adverse effects can be increased when Parathyroid hormone is combined with Digoxin"
                    },
                    {
                        "drugbank-id": "DB00511",
                        "description": "The risk or severity of adverse effects can be increased when Parathyroid hormone is combined with Acetyldigitoxin"
                    },
                    {
                        "drugbank-id": "DB01078",
                        "description": "The risk or severity of adverse effects can be increased when Parathyroid hormone is combined with Deslanoside"
                    },
                    {
                        "drugbank-id": "DB01092",
                        "description": "The risk or severity of adverse effects can be increased when Parathyroid hormone is combined with Ouabain"
                    },
                    {
                        "drugbank-id": "DB01396",
                        "description": "The risk or severity of adverse effects can be increased when Parathyroid hormone is combined with Digitoxin"
                    },
                    {
                        "drugbank-id": "DB12843",
                        "description": "The risk or severity of adverse effects can be increased when Parathyroid hormone is combined with Oleandrin"
                    },
                    {
                        "drugbank-id": "DB13240",
                        "description": "The risk or severity of adverse effects can be increased when Parathyroid hormone is combined with Cymarin"
                    },
                    {
                        "drugbank-id": "DB13307",
                        "description": "The risk or severity of adverse effects can be increased when Parathyroid hormone is combined with Proscillaridin"
                    },
                    {
                        "drugbank-id": "DB13401",
                        "description": "The risk or severity of adverse effects can be increased when Parathyroid hormone is combined with Metildigoxin"
                    },
                    {
                        "drugbank-id": "DB13467",
                        "description": "The risk or severity of adverse effects can be increased when Parathyroid hormone is combined with Lanatoside C"
                    },
                    {
                        "drugbank-id": "DB13537",
                        "description": "The risk or severity of adverse effects can be increased when Parathyroid hormone is combined with Gitoformate"
                    },
                    {
                        "drugbank-id": "DB13691",
                        "description": "The risk or severity of adverse effects can be increased when Parathyroid hormone is combined with Acetyldigoxin"
                    },
                    {
                        "drugbank-id": "DB13756",
                        "description": "The risk or severity of adverse effects can be increased when Parathyroid hormone is combined with Peruvoside"
                    },
                    {
                        "drugbank-id": "DB00176",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Fluvoxamine"
                    },
                    {
                        "drugbank-id": "DB00215",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Citalopram"
                    },
                    {
                        "drugbank-id": "DB00472",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Fluoxetine"
                    },
                    {
                        "drugbank-id": "DB00476",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Duloxetine"
                    },
                    {
                        "drugbank-id": "DB00656",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Trazodone"
                    },
                    {
                        "drugbank-id": "DB00715",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Paroxetine"
                    },
                    {
                        "drugbank-id": "DB01104",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Sertraline"
                    },
                    {
                        "drugbank-id": "DB01105",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Sibutramine"
                    },
                    {
                        "drugbank-id": "DB01149",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Nefazodone"
                    },
                    {
                        "drugbank-id": "DB01175",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Escitalopram"
                    },
                    {
                        "drugbank-id": "DB04832",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Zimelidine"
                    },
                    {
                        "drugbank-id": "DB04884",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Dapoxetine"
                    },
                    {
                        "drugbank-id": "DB04896",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Milnacipran"
                    },
                    {
                        "drugbank-id": "DB06700",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Desvenlafaxine"
                    },
                    {
                        "drugbank-id": "DB06731",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Seproxetine"
                    },
                    {
                        "drugbank-id": "DB08918",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Levomilnacipran"
                    },
                    {
                        "drugbank-id": "DB08953",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Indalpine"
                    },
                    {
                        "drugbank-id": "DB12693",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Ritanserin"
                    },
                    {
                        "drugbank-id": "DB13233",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Alaproclate"
                    },
                    {
                        "drugbank-id": "DB00282",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Pamidronic acid"
                    },
                    {
                        "drugbank-id": "DB00399",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Zoledronic acid"
                    },
                    {
                        "drugbank-id": "DB00630",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Alendronic acid"
                    },
                    {
                        "drugbank-id": "DB00710",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Ibandronate"
                    },
                    {
                        "drugbank-id": "DB00720",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Clodronic acid"
                    },
                    {
                        "drugbank-id": "DB00884",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Risedronic acid"
                    },
                    {
                        "drugbank-id": "DB01077",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01133",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Tiludronic acid"
                    },
                    {
                        "drugbank-id": "DB06255",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Incadronic acid"
                    },
                    {
                        "drugbank-id": "DB00182",
                        "description": "The risk or severity of adverse effects can be increased when Amphetamine is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB00191",
                        "description": "The risk or severity of adverse effects can be increased when Phentermine is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB00211",
                        "description": "The risk or severity of adverse effects can be increased when Midodrine is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB00368",
                        "description": "The risk or severity of adverse effects can be increased when Norepinephrine is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB00388",
                        "description": "The risk or severity of adverse effects can be increased when Phenylephrine is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB00397",
                        "description": "The risk or severity of adverse effects can be increased when Phenylpropanolamine is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB00610",
                        "description": "The risk or severity of adverse effects can be increased when Metaraminol is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB00668",
                        "description": "The risk or severity of adverse effects can be increased when Epinephrine is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB00723",
                        "description": "The risk or severity of adverse effects can be increased when Methoxamine is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB00816",
                        "description": "The risk or severity of adverse effects can be increased when Orciprenaline is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB00830",
                        "description": "The risk or severity of adverse effects can be increased when Phenmetrazine is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB00841",
                        "description": "The risk or severity of adverse effects can be increased when Dobutamine is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB00852",
                        "description": "The risk or severity of adverse effects can be increased when Pseudoephedrine is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB00865",
                        "description": "The risk or severity of adverse effects can be increased when Benzphetamine is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB00867",
                        "description": "The risk or severity of adverse effects can be increased when Ritodrine is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB00871",
                        "description": "The risk or severity of adverse effects can be increased when Terbutaline is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB00935",
                        "description": "The risk or severity of adverse effects can be increased when Oxymetazoline is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB00937",
                        "description": "The risk or severity of adverse effects can be increased when Diethylpropion is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB00988",
                        "description": "The risk or severity of adverse effects can be increased when Dopamine is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB01064",
                        "description": "The risk or severity of adverse effects can be increased when Isoprenaline is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB01255",
                        "description": "The risk or severity of adverse effects can be increased when Lisdexamfetamine is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB01288",
                        "description": "The risk or severity of adverse effects can be increased when Fenoterol is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB01364",
                        "description": "The risk or severity of adverse effects can be increased when Ephedrine is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB01365",
                        "description": "The risk or severity of adverse effects can be increased when Mephentermine is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB01366",
                        "description": "The risk or severity of adverse effects can be increased when Procaterol is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB01407",
                        "description": "The risk or severity of adverse effects can be increased when Clenbuterol is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB01442",
                        "description": "The risk or severity of adverse effects can be increased when MMDA is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB01454",
                        "description": "The risk or severity of adverse effects can be increased when Midomafetamine is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB01467",
                        "description": "The risk or severity of adverse effects can be increased when 2 5 Dimethoxy 4 ethylamphetamine is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB01484",
                        "description": "The risk or severity of adverse effects can be increased when 4 Bromo 2 5 dimethoxyamphetamine is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB01509",
                        "description": "The risk or severity of adverse effects can be increased when Tenamfetamine is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB01556",
                        "description": "The risk or severity of adverse effects can be increased when Chlorphentermine is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB01566",
                        "description": "The risk or severity of adverse effects can be increased when Methylenedioxyethamphetamine is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB01576",
                        "description": "The risk or severity of adverse effects can be increased when Dextroamphetamine is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB01577",
                        "description": "The risk or severity of adverse effects can be increased when Metamfetamine is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB06152",
                        "description": "The risk or severity of adverse effects can be increased when Nylidrin is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB06764",
                        "description": "The risk or severity of adverse effects can be increased when Tetryzoline is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB08841",
                        "description": "The risk or severity of adverse effects can be increased when Tyramine is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB08941",
                        "description": "The risk or severity of adverse effects can be increased when Isoxsuprine is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB08985",
                        "description": "The risk or severity of adverse effects can be increased when Etilefrine is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB09203",
                        "description": "The risk or severity of adverse effects can be increased when Synephrine is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB09480",
                        "description": "The risk or severity of adverse effects can be increased when Iofetamine I 123 is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB11124",
                        "description": "The risk or severity of adverse effects can be increased when Racepinephrine is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB12080",
                        "description": "The risk or severity of adverse effects can be increased when Ritobegron is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB13064",
                        "description": "The risk or severity of adverse effects can be increased when Tramazoline is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB13108",
                        "description": "The risk or severity of adverse effects can be increased when Mephedrone is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB13341",
                        "description": "The risk or severity of adverse effects can be increased when Fenozolone is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB13624",
                        "description": "The risk or severity of adverse effects can be increased when Methoxyphenamine is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB13692",
                        "description": "The risk or severity of adverse effects can be increased when Tretoquinol is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB13703",
                        "description": "The risk or severity of adverse effects can be increased when Gepefrine is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB13777",
                        "description": "The risk or severity of adverse effects can be increased when Prenalterol is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB13852",
                        "description": "The risk or severity of adverse effects can be increased when Mefenorex is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB13940",
                        "description": "The risk or severity of adverse effects can be increased when 2 5 Dimethoxy 4 ethylthioamphetamine is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB00598",
                        "description": "The risk or severity of adverse effects can be increased when Labetalol is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB01193",
                        "description": "The risk or severity of adverse effects can be increased when Acebutolol is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB04846",
                        "description": "The risk or severity of adverse effects can be increased when Celiprolol is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB12752",
                        "description": "The risk or severity of adverse effects can be increased when Bucindolol is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB13757",
                        "description": "The risk or severity of adverse effects can be increased when Epanolol is combined with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB00317",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Gefitinib"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Sorafenib"
                    },
                    {
                        "drugbank-id": "DB00530",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Erlotinib"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Imatinib"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Dasatinib"
                    },
                    {
                        "drugbank-id": "DB01259",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01268",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Sunitinib"
                    },
                    {
                        "drugbank-id": "DB01645",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Genistein"
                    },
                    {
                        "drugbank-id": "DB02058",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with 3 4 1 formylpiperazin 4 yl benzylidenyl 2 indolinone"
                    },
                    {
                        "drugbank-id": "DB02424",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Geldanamycin"
                    },
                    {
                        "drugbank-id": "DB02567",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with PD173955"
                    },
                    {
                        "drugbank-id": "DB03758",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Radicicol"
                    },
                    {
                        "drugbank-id": "DB04849",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Cediranib"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Nilotinib"
                    },
                    {
                        "drugbank-id": "DB04879",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Vatalanib"
                    },
                    {
                        "drugbank-id": "DB05294",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Vandetanib"
                    },
                    {
                        "drugbank-id": "DB05424",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Canertinib"
                    },
                    {
                        "drugbank-id": "DB05465",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Tandutinib"
                    },
                    {
                        "drugbank-id": "DB05575",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Motesanib"
                    },
                    {
                        "drugbank-id": "DB05928",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Dovitinib"
                    },
                    {
                        "drugbank-id": "DB06302",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Glesatinib"
                    },
                    {
                        "drugbank-id": "DB06469",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Lestaurtinib"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Pazopanib"
                    },
                    {
                        "drugbank-id": "DB06595",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Midostaurin"
                    },
                    {
                        "drugbank-id": "DB06616",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Bosutinib"
                    },
                    {
                        "drugbank-id": "DB06626",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Axitinib"
                    },
                    {
                        "drugbank-id": "DB08399",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Piceatannol"
                    },
                    {
                        "drugbank-id": "DB08865",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Crizotinib"
                    },
                    {
                        "drugbank-id": "DB08875",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Cabozantinib"
                    },
                    {
                        "drugbank-id": "DB08877",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Ruxolitinib"
                    },
                    {
                        "drugbank-id": "DB08881",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Vemurafenib"
                    },
                    {
                        "drugbank-id": "DB08896",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Regorafenib"
                    },
                    {
                        "drugbank-id": "DB08901",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Ponatinib"
                    },
                    {
                        "drugbank-id": "DB08916",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Afatinib"
                    },
                    {
                        "drugbank-id": "DB09053",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Ibrutinib"
                    },
                    {
                        "drugbank-id": "DB09063",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Ceritinib"
                    },
                    {
                        "drugbank-id": "DB09078",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Lenvatinib"
                    },
                    {
                        "drugbank-id": "DB09079",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Nintedanib"
                    },
                    {
                        "drugbank-id": "DB09330",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Osimertinib"
                    },
                    {
                        "drugbank-id": "DB11363",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Alectinib"
                    },
                    {
                        "drugbank-id": "DB11689",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Selumetinib"
                    },
                    {
                        "drugbank-id": "DB11697",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Pacritinib"
                    },
                    {
                        "drugbank-id": "DB11703",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Acalabrutinib"
                    },
                    {
                        "drugbank-id": "DB11737",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Icotinib"
                    },
                    {
                        "drugbank-id": "DB11805",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Saracatinib"
                    },
                    {
                        "drugbank-id": "DB11828",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Neratinib"
                    },
                    {
                        "drugbank-id": "DB11832",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Crenolanib"
                    },
                    {
                        "drugbank-id": "DB11904",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Flumatinib"
                    },
                    {
                        "drugbank-id": "DB11963",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Dacomitinib"
                    },
                    {
                        "drugbank-id": "DB11973",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Tesevatinib"
                    },
                    {
                        "drugbank-id": "DB11986",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Entrectinib"
                    },
                    {
                        "drugbank-id": "DB12010",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Fostamatinib"
                    },
                    {
                        "drugbank-id": "DB12048",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Savolitinib"
                    },
                    {
                        "drugbank-id": "DB12141",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Gilteritinib"
                    },
                    {
                        "drugbank-id": "DB12147",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Erdafitinib"
                    },
                    {
                        "drugbank-id": "DB12267",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Brigatinib"
                    },
                    {
                        "drugbank-id": "DB12307",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Foretinib"
                    },
                    {
                        "drugbank-id": "DB12323",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Radotinib"
                    },
                    {
                        "drugbank-id": "DB14723",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB12978",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Pexidartinib"
                    },
                    {
                        "drugbank-id": "DB12500",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Fedratinib"
                    },
                    {
                        "drugbank-id": "DB11652",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Tucatinib"
                    },
                    {
                        "drugbank-id": "DB11791",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Capmatinib"
                    },
                    {
                        "drugbank-id": "DB15685",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Selpercatinib"
                    },
                    {
                        "drugbank-id": "DB05258",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Interferon alfa"
                    },
                    {
                        "drugbank-id": "DB00041",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Aldesleukin"
                    },
                    {
                        "drugbank-id": "DB00227",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Lovastatin"
                    },
                    {
                        "drugbank-id": "DB00609",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Ethionamide"
                    },
                    {
                        "drugbank-id": "DB00829",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Diazepam"
                    },
                    {
                        "drugbank-id": "DB00850",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Perphenazine"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Metoclopramide"
                    },
                    {
                        "drugbank-id": "DB14651",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Perphenazine enanthate"
                    },
                    {
                        "drugbank-id": "DB00233",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Aminosalicylic acid"
                    },
                    {
                        "drugbank-id": "DB11085",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Resorcinol"
                    },
                    {
                        "drugbank-id": "DB00222",
                        "description": "The therapeutic efficacy of Glimepiride can be decreased when used in combination with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB00414",
                        "description": "The therapeutic efficacy of Acetohexamide can be decreased when used in combination with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB00672",
                        "description": "The therapeutic efficacy of Chlorpropamide can be decreased when used in combination with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB00839",
                        "description": "The therapeutic efficacy of Tolazamide can be decreased when used in combination with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB01016",
                        "description": "The therapeutic efficacy of Glyburide can be decreased when used in combination with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB01067",
                        "description": "The therapeutic efficacy of Glipizide can be decreased when used in combination with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB01120",
                        "description": "The therapeutic efficacy of Gliclazide can be decreased when used in combination with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB01124",
                        "description": "The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB01251",
                        "description": "The therapeutic efficacy of Gliquidone can be decreased when used in combination with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB01289",
                        "description": "The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB08962",
                        "description": "The therapeutic efficacy of Glibornuride can be decreased when used in combination with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB13406",
                        "description": "The therapeutic efficacy of Carbutamide can be decreased when used in combination with Parathyroid hormone"
                    },
                    {
                        "drugbank-id": "DB13675",
                        "description": "The therapeutic efficacy of Metahexamide can be decreased when used in combination with Parathyroid hormone"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}